Nausea and vomiting rates for the monthly injectable berobenatide came in close to benchmarks set by Novo Nordisk's weekly ...
Pfizer executives said most patients experienced few or mild side effects, with gastrointestinal events largely limited ​to ...
With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...